Swiss healthcare firm Roche Diagnostics has launched a new diagnostics legal entity in Nigeria to deepen access to innovative healthcare and improve diagnostics capacity across West Africa.

Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread ...

Swiss healthcare firm Roche Diagnostics has launched a new diagnostics legal entity in Nigeria to deepen access to innovative healthcare and improve diagnostics capacity across West Africa.According ...

Les Roches, ranked No.2 worldwide in higher education for hospitality and leisure management (QS World University Rankings, ...

Peter Ahnesorg is the new head of Roche Hungary’s pharmaceuticals division, replacing Raffaella Claudia Bondi, who led the ...

Three top ministers are abroad this week because export-reliant Switzerland is in danger of being caught in the trade war ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA ; Evrysdi offers the same efficacy and safety demo ...

«Investing in the United States entails risks in view of the great uncertainty surrounding economic policies, and would run ...

The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in ...